Private Label CGM: Launch Your Own Glucose Monitoring Brand

Most companies that want their own CGM brand never get past the first phone call. They talk to a manufacturer, hear about minimum orders in the hundreds of thousands of units, development timelines measured in years, and regulatory submissions they would have to fund themselves — and they conclude that continuous glucose monitoring is a two-company market that doesn't need a third player.

That conclusion is wrong, and the gap between "building a CGM from scratch" and "not entering the market at all" is exactly where private label CGM sits.

A private label CGM is a complete, factory-validated monitoring system — sensor, applicator, transmitter and app — that you sell under your own brand. The engineering, the clinical validation and the manufacturing are done. You bring the brand, the market and the customers.

This guide covers how the private label model works, what you can and cannot customize, how it differs from OEM and SKD, what it typically costs and how long it takes, and how to pick a manufacturing partner you will still be working with in five years.

Verid Bio was the first CGM provider to enable SKD/CKD production models overseas. Private label is the fastest route into that same ecosystem — this guide draws on what we have watched distributors and brands actually get wrong and right.

What is a private label CGM?

A CGM is a system, not a single device. A complete consumer experience needs at least four things working together:

• The sensor — the sterile, single-use component worn on the body for the wear period (our platform: 15 days per sensor)
• The applicator — the one-button device that inserts the sensor
• The transmitter/reader logic — electronics that read the sensor and get the data out
• The software — the mobile app that shows glucose values, trends and alerts

In a private label arrangement, all four already exist. The manufacturer has designed them, validated them clinically, taken them through manufacturing qualification, and produces them at scale. You put your brand on the packaging, the hardware and the app, and you sell the result as your product.

What you do not do is what makes the model attractive:

• No electrochemistry or membrane development
• No sensor stability studies from zero
• No cleanroom or micro-assembly line
• No multi-year regulatory build from a blank page

You are buying a validated platform and renting the hardest parts of the value chain, then competing on brand, distribution and market fit — which is usually what you were good at anyway.

Why more companies are choosing private label CGM

The commercial logic is straightforward, and it explains why the model has moved from niche to mainstream in under three years.

1. Speed to market. A ground-up CGM program is a multi-year effort before the first sale. A private label program is typically measured in months from signed agreement to first shipment, because the long-lead work — sensor chemistry, wear-time validation, manufacturing qualification — already exists.

2. Capital efficiency. The money that would have gone into a sensor R&D lab and a clinical program instead goes into the things that actually win your market: distribution, marketing, clinical relationships and local service. For most brands, that trade is obviously correct.

3. De-risked technology. A serious private label platform has already survived the failure modes that kill first-generation CGM products: calibration drift, adhesive failures, warm-up instability, app crashes in the field. You inherit that history instead of paying for it.

4. Strategic focus. If your advantage is regional distribution, pharmacy relationships, telehealth reach or a consumer brand, building biosensors is a distraction. Private label lets you stay in your lane and still own the customer relationship.

The market backdrop supports the move: industry analysts put the global CGM market in the multi-billion-dollar range with double-digit annual growth, driven less by type 1 diabetes alone and more by type 2 management, metabolic health and general wellness adoption. The customer base is widening faster than incumbent supply chains can serve it — which is precisely the window private label programs exploit.

Private label vs. OEM vs. SKD: what is the difference?

These three models get used interchangeably in sales conversations, and that confusion costs buyers money. They differ in how much you build, how much you customize, and who carries the regulatory burden.

	Private label	OEM / ODM	SKD / CKD
What you get	Finished, validated system under your brand	Platform adapted to your specification	Kit of parts, assembled locally
Customization depth	Packaging, branding, app skin, configuration	Hardware, form factor, features, firmware	Deepest — local value addition
Engineering effort for you	Minimal	Moderate	High
Time to first sale	Fastest (months)	Medium	Longest
Local manufacturing story	None	Partial	Strongest — can qualify as locally made
Typical use case	Brand entering the market fast	Brand with specific product requirements	Tenders, local-content rules, tariff reduction

A more detailed breakdown lives in our guide to CGM OEM vs SKD vs CKD, and the kit-level mechanics are covered in what is CGM SKD.

The practical way to choose:

• Validating a market or launching a brand → private label. Lowest commitment, fastest feedback.
• You have hard product requirements (different form factor, specific features) → OEM.
• You face tenders, local-content requirements or punishing import duties → SKD/CKD.

Many of the best programs we see start private label and migrate toward deeper models once the market is proven. The models are stages, not ideologies.

Who actually uses private label CGM?

The model is not just for startups. The buyers we see most often:

• Medical device distributors with an established regional channel who want to own the brand instead of reselling someone else's
• Diabetes care and metabolic health brands that already have the audience and need the product
• Pharma and supplement companies adding monitoring to an existing therapy or wellness portfolio
• Telehealth and RPM platforms that need a sensor to complete a remote-care offering
• Importers and tender bidders preparing for public procurement where brand ownership matters

What they share is distribution power and a customer relationship — the two things a factory cannot give them, and the two things that decide who wins a market.

What can you actually customize?

"Private label" is sometimes heard as "identical product with your sticker on it." That is a misunderstanding, and it is worth killing now. On a mature platform you can typically customize:

• Packaging and unboxing — box design, inserts, quick-start guides, language localization
• Hardware branding — logo placement on applicator and transmitter, brand colors
• App identity — your brand name and colors in the patient app, localized strings, feature toggles
• Clinical configuration — alert thresholds and notification behavior aligned to your market's expectations
• Commercial terms — kit composition (sensors per box), wear-period positioning, bundle structure

What you should not expect to change on a private label program: the sensing chemistry, the wear-time claim and the core algorithm. Those are the validated, regulated heart of the product — changing them is what turns a private label program into an OEM program with OEM timelines.

What does it cost, and how long does it take?

Two questions every serious buyer asks, and where vague answers should make you walk away.

Timeline. For a private label launch on an existing platform, expect the sequence to run in months, not years: regulatory path confirmation for your market, brand asset production, packaging and app branding, sample evaluation, then first production run. The single biggest schedule risk is usually your own market's registration path, not the factory.

Cost structure. Rather than a fixed price list, expect three cost layers:

1. Program setup — branding, packaging design, app branding, registration support
2. Per-unit cost — driven by kit composition, order volume and configuration
3. Regulatory and market entry — local registration, import licensing, any local testing

Beware of any quotation that only shows the per-unit price. The program costs are where budgets get destroyed, and an honest manufacturer will show them to you upfront. When you compare quotes between manufacturers, compare the total program cost at your realistic first-year volume, not the headline unit price.

How to choose a private label CGM manufacturer

This is the decision that matters, because switching manufacturers later means re-branding, re-registering and re-training your market. Four criteria, in order of importance:

1. Clinical accuracy — with the study behind it. Every CGM company quotes a MARD number. Few volunteer the study design behind it: how many subjects, over how many days, against what reference, in what glycemic ranges. Ask for the data, not the acronym. Our guide to understanding MARD covers what a good answer sounds like.

2. Wear time that survives contact with real skin. A wear-time claim is a promise your brand will have to keep thousands of times. Ask how the wear period was validated, what the actual adhesive failure rates look like, and what happens on day 13 of a 15-day sensor. This is where brands quietly bleed reputation.

3. Regulatory documentation depth. You will need technical files, test reports, biocompatibility documentation, sterilization validation and quality-system certificates to register the product in your market. Ask to see the document list before you sign — the depth of that list tells you how many surprises your registration will contain.

4. Long-term commitment. CGM is not a one-purchase product; your customers will buy sensors for years. Ask about the sensor supply roadmap, successor products, and how app and algorithm updates are handled. A manufacturer that cannot describe the next three years of the platform is renting you a product, not partnering.

Our fuller checklist lives in how to choose a CGM SKD manufacturer — the criteria apply to private label with minor adjustments.

Frequently asked questions

Is private label the same as white label?

For practical purposes, yes. "White label CGM" and "private label CGM" both describe selling a manufacturer's validated product under your own brand. Some industry participants use "white label" for the most standardized version of the arrangement and "private label" where branding and configuration go deeper — but you should always ask a specific manufacturer what their label includes rather than relying on the terminology.

Is private label different from OEM?

Yes, and the difference is schedule and depth. Private label sells an existing validated platform under your brand. OEM modifies the platform to your specification — different hardware, features or form factor — which adds engineering and validation time. If your requirements are genuinely standard, private label gets you to market faster at lower cost. Our CGM OEM vs SKD vs CKD comparison breaks down the decision.

Can I legally sell a CGM under my own brand name?

Yes — this is an established, lawful model in most markets, and it is how much of the medical device industry has always worked. The brand owner or importer typically needs to hold the appropriate market registration or licensing in the destination country, and the manufacturer must supply the technical documentation to support it. Requirements vary by market, so confirm the registration path early — it is usually the longest lead item in the plan.

Do I need to develop my own sensor?

No. That is the entire point of the model. The sensing platform — chemistry, membrane, calibration, wear-time validation — is supplied as-is. Developing your own sensor means building an electrochemistry team, a cleanroom and a clinical program, which is the multi-year path this model exists to avoid.

Can the mobile app carry my brand?

On a mature platform, yes: app name, icon, colors and localized content are normally part of the private label package, along with configurable alerts and feature toggles. Ask to see a branded build early in the evaluation — it is the fastest way to judge how real a manufacturer's "customization" promises are.

What certifications should I look for?

At minimum, expect a quality management system certificate (ISO 13485 is the global baseline for medical device manufacturing) plus the market-specific approvals relevant to your destination — CE marking for Europe, for example, or the local authority registration elsewhere. Beyond the certificates, ask for the supporting technical documentation: biocompatibility, sterilization validation and the clinical performance study. Certificates are easy to claim; document sets are harder to fake.

Can a small company realistically do this?

Yes, and smaller companies are often the best private label customers — they decide quickly and execute their launch channels well. What a small company needs is a realistic first-order volume, a clear idea of its registration path, and a distribution or customer-acquisition plan. What it does not need is a sensor lab.

How is this different from just reselling someone's CGM?

In a resale arrangement, the manufacturer's brand stays on the product and you compete on price and availability. In a private label arrangement, the customer relationship, the brand and the repurchase loop belong to you — which changes your margins, your pricing power and the long-term value of every customer you acquire. That ownership of the repurchase cycle is usually the entire business case.

The next step

Private label CGM works best for organizations that already own a market relationship and want to convert it into a product business without funding a sensor program. If that describes you, the useful next conversation is a specific one: your market, your regulatory path and your expected first-year volume.

Tell us those three things and we will tell you honestly whether private label, OEM or SKD is the right entry model — and what the first twelve months look like.

Contact Verid Bio at contact@verid.bio.